Using an ovarian cancer dataset, we show that MAYA identifies several modes of pathway activation shared across patients (Fig. 5a–c and Supplementary Fig. 5a, b) that are associated with known cancer hallmarks. This evidence concerns the gene MNX1-AS1 and cancer.